Download | < Back |
04 Nov 2014 | |
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated November 04, 2014, titled "Enrollment Begins of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis". | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |